1. Home
  2. SLNG vs BMEA Comparison

SLNG vs BMEA Comparison

Compare SLNG & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$3.73

Market Cap

103.2M

Sector

Utilities

ML Signal

HOLD

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.88

Market Cap

107.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
BMEA
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
107.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
SLNG
BMEA
Price
$3.73
$1.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$10.00
$8.86
AVG Volume (30 Days)
75.5K
1.6M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
69.19
EPS
N/A
N/A
Revenue
$68,245,000.00
N/A
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.21
$0.87
52 Week High
$6.36
$3.07

Technical Indicators

Market Signals
Indicator
SLNG
BMEA
Relative Strength Index (RSI) 39.23 74.53
Support Level $3.25 $1.77
Resistance Level $5.08 $2.06
Average True Range (ATR) 0.53 0.14
MACD -0.00 0.06
Stochastic Oscillator 22.29 98.81

Price Performance

Historical Comparison
SLNG
BMEA

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Share on Social Networks: